Dr. Ramanathan is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Connect with other colleagues in the same hospital or clinic
- Search all U.S. specialist profiles and refer a patient
- Read the latest clinical news and earn CME/CEU credits
Office
55 Lake Ave N
Worcester, MA 01655Phone+1 508-856-3903- Is this information wrong?
Summary
- Dr. Muthalagu Ramanathan is an oncologist in Worcester, MA and is affiliated with UMass Memorial Medical Center. She received her medical degree from Kilpauk Medical College and has been in practice 20 years. She specializes in hematologic oncology and is experienced in hematopoietic stem cell transplantation, hodgkin's lymphoma, and transplantation conditioning. She has more than 40 publications and over 500 citings.
Education & Training
National Capital ConsortiumFellowship, Hematology and Medical Oncology, 2006 - 2009
Roger Williams Medical CenterResidency, Internal Medicine, 2002 - 2005
Kilpauk Medical CollegeClass of 1997
Certifications & Licensure
MA State Medical License 2009 - 2024
RI State Medical License 2004 - 2010- American Board of Internal Medicine Hematology
- American Board of Internal Medicine Medical Oncology
Awards, Honors, & Recognition
- Meaningful Use Stage 1 Certification Centers for Medicare & Medicaid Services, 2011
Clinical Trials
- Lenalidomide With or Without Epoetin Alfa in Treating Patients With Myelodysplastic Syndrome and Anemia Start of enrollment: 2009 Jan 29
- Chronic Graft-versus-Host Disease Treatment (BMT CTN 0801) Start of enrollment: 2010 Apr 01
- Ibrutinib and Rituximab Compared With Fludarabine Phosphate, Cyclophosphamide, and Rituximab in Treating Patients With Untreated Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma Start of enrollment: 2014 Feb 20
Publications & Presentations
PubMed
- Natural history of clonal haematopoiesis seen in real-world haematology settings.William K Gerber, Lloyd Hutchinson, Brandon A DaSilva, Patricia M Miron, Anne W Higgins, Shyam A Patel, Rena Zheng, Shrinkhala Khanna, Gregory A Abel, Jan Cerny, Tian ...> ;British Journal of Haematology. 2024 Mar 24
- Midostaurin for FLT3-mutated AML: a real-world analysis of effectiveness and infection risk at a single center.Patel, S., Ramanathan, M., Gerber, J., Cerny, J., Kennedy, A.> ;Annals of Hematology. 2024 Mar 1
- 3 citationsPrognostic heterogeneity and clonal dynamics within distinct subgroups of myelodysplastic syndrome and acute myeloid leukemia withdisruptions.Shyam A Patel, Jan Cerny, William K Gerber, Muthalagu Ramanathan, Asiri Ediriwickrema, Benjamin Tanenbaum, Lloyd Hutchinson, Xiuling Meng, Julie Flahive, Bruce Barton,...> ;Ejhaem. 2023 Nov 1
- Join now to see all
Journal Articles
- The incidence and impact of clostridioides difficile infection on transplant outcomes in acute leukemia and MDS after allogeneic hematopoietic cell transplant—a CIBMTR...Muthalagu Ramanathan et al, Bone marrow transplant, 12/21/2022
Lectures
- High Dose Mitoxantrone Based “5+1” Induction Chemotherapy Regimen in Newly Diagnosed Acute Myeloid Leukemia2018 ASH Annual Meeting - San Diego, CA - 12/1/2018
- Hematopoeitic Cell Transplant - Comorbidity Index (HCT-CI) Score Is a Useful Tool for Predicting Induction Mortality and Overall Survival in Newly Diagnosed Acute Myel...2018 ASH Annual Meeting - San Diego, CA - 12/1/2018
Authored Content
- CDiff incidence and impact post allo sctDecember 2022
Hospital Affiliations
UMass Memorial Medical CenterWorcester, Massachusetts
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
